CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,299 | $461.17 | $599K | 2,070 |
| 2025-11-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,290 | $1,290.00 | $1.7M | 780 |
| 2025-11-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −650 | $467.39 | $304K | 130 |
| 2025-11-13 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 98,000 | ||
| 2025-11-12 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-11-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −500 | $455.97 | $228K | 3,630 |
| 2025-11-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −520 | $457.54 | $238K | 3,110 |
| 2025-11-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −980 | $458.71 | $450K | 2,130 |
| 2025-11-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −800 | $461.14 | $369K | 1,330 |
| 2025-11-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −200 | $462.02 | $92K | 1,130 |
| 2025-11-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,000 | $463.24 | $463K | 130 |
| 2025-11-12 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 102,000 | ||
| 2025-11-11 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-11-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,097 | $450.64 | $494K | 3,033 |
| 2025-11-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,634 | $451.87 | $738K | 1,399 |
| 2025-11-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,269 | $452.78 | $575K | 130 |
| 2025-11-11 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 106,000 | ||
| 2025-11-10 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | −14,625 | $135.42 | $2.0M | 14,625 |
| 2025-11-10 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −14,625 | $452.09 | $6.6M | 0 |
| 2025-11-10 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +7,875 | $146.03 | $1.1M | 7,875 |
Page 183 of 214 · 4,273 trades